State of Wyoming Makes New Investment in Aveanna Healthcare Holdings Inc. $AVAH

State of Wyoming purchased a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 51,723 shares of the company’s stock, valued at approximately $443,000.

Other large investors also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd increased its holdings in Aveanna Healthcare by 252.4% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares in the last quarter. Quantbot Technologies LP bought a new position in Aveanna Healthcare in the second quarter valued at about $43,000. Summit Securities Group LLC acquired a new stake in shares of Aveanna Healthcare during the first quarter valued at about $53,000. Oxford Asset Management LLP acquired a new stake in shares of Aveanna Healthcare during the second quarter valued at about $64,000. Finally, Bayesian Capital Management LP bought a new stake in shares of Aveanna Healthcare during the second quarter worth about $85,000. 87.96% of the stock is currently owned by institutional investors.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, insider Patrick A. Cunningham sold 125,000 shares of the stock in a transaction that occurred on Wednesday, May 20th. The stock was sold at an average price of $7.59, for a total value of $948,750.00. Following the transaction, the insider owned 212,755 shares in the company, valued at approximately $1,614,810.45. This represents a 37.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the firm’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total value of $19,376,470.35. Following the completion of the sale, the insider directly owned 10,112,123 shares of the company’s stock, valued at $80,998,105.23. This trade represents a 19.30% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 31,305,664 shares of company stock valued at $215,555,910. 5.30% of the stock is currently owned by corporate insiders.

Aveanna Healthcare Stock Performance

NASDAQ:AVAH opened at $12.69 on Tuesday. The company has a fifty day moving average of $9.10 and a 200-day moving average of $7.78. The firm has a market capitalization of $2.77 billion, a P/E ratio of 10.32, a P/E/G ratio of 1.22 and a beta of 1.90. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare Holdings Inc. has a twelve month low of $5.93 and a twelve month high of $12.70.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. The business had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. As a group, sell-side analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on AVAH shares. Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. UBS Group raised their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research note on Friday. Raymond James Financial lifted their price target on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a report on Friday. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Finally, Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $11.78.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.